Nordisks
-
USA
Novo Nordisk’s Wegovy pill launch draws new wave of patients to GLP-1s
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t…
Read More » -
USA
FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
Read More » -
USA
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk It became the first company to produce the GLP-1 drug for weight loss and became the most valuable…
Read More » -
USA
FDA says Novo Nordisk’s obesity pill TV ad includes misleading claims
Still life of new Wegovy semaglutide tablets on white background. It is a prescription medication used in conjunction with a…
Read More » -
USA
Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight loss pill
Close-up of a hand holding a mobile phone showing the Amazon Pharmacy system, Lafayette, California, September 15, 2021. Smith Collection…
Read More » -
USA
Novo Nordisk’s strategy tested as investors push back on board revamp
Flags bearing the logos of Danish drugmaker Novo Nordisk, maker of blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, are…
Read More » -
USA
Metsera calls Novo Nordisk’s new bid superior to Pfizer offer
Logos of Danish pharmaceutical manufacturer Novo Nordisk, maker of blockbuster diabetes and weight loss treatments Ozempic and Wegovy, are seen…
Read More » -
USA
Novo Nordisk’s Martin Holst Lange previews obesity pill
A version of this article was first published in the CNBC’s healthy return bulletin, which brought the latest health news…
Read More » -
USA
Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug
A sign with the company logo is sitting outside the center of Eli Lilly in Indiana, Indiana, Indiana on 17…
Read More » -
UK
Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply | Pharmaceuticals industry
The sales of injectable diabetes drugs, including Novo Nordisk’s Ozempic, slowed down sharply in the midst of the threat of…
Read More »